Prognostic Implications of Heterogeneity in Intra-tumoral Immune Composition for Recurrence in Early Stage Lung Cancer
Background: Studies in the past have identified selected immune cells that associate with different clinical outcomes in non-small cell lung cancer (NSCLC). Considering the fact that immune responses are heterogenous and that the clinical outcome could be influenced by the interplay of various immun...
Main Authors: | Jyothi Thyagabhavan Mony, Matthew J. Schuchert |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2018.02298/full |
Similar Items
-
Immune landscape and a promising immune prognostic model associated with TP53 in early‐stage lung adenocarcinoma
by: Chengde Wu, et al.
Published: (2021-02-01) -
BTK Has Potential to Be a Prognostic Factor for Lung Adenocarcinoma and an Indicator for Tumor Microenvironment Remodeling: A Study Based on TCGA Data Mining
by: Ke-Wei Bi, et al.
Published: (2020-04-01) -
Different pathologic types of early stage lung adenocarcinoma have different post‐operative recurrence patterns
by: Xianping Liu, et al.
Published: (2021-08-01) -
A novel recurrence-associated metabolic prognostic model for risk stratification and therapeutic response prediction in patients with stage I lung adenocarcinoma
by: Chengming Liu, et al.
Published: (2021-08-01) -
Histological and prognostic data on surgically resected early-stage lung adenocarcinoma
by: Masaya Yotsukura, MD, et al.
Published: (2020-08-01)